Marty Makary resigns as FDA commissioner after internal tensions
Summary
Marty Makary resigned as commissioner of the Food and Drug Administration (FDA) due to disagreements over policies, including the approval of flavored e-cigarettes. Reports say President Trump pressured Makary to approve fruit-flavored vapes despite Makary’s objections. His departure follows other recent leadership changes within the FDA.Key Facts
- Marty Makary stepped down as FDA commissioner amid internal conflicts.
- The FDA approved some flavored e-cigarettes from Glas Inc. after pressure from President Trump.
- Makary reportedly opposed approving fruit-flavored vapes but was forced by the administration to do so.
- President Trump called Makary a "great guy" but acknowledged he was facing difficulties.
- Makary was expected to testify before Congress but will be replaced by acting commissioner Kyle Diamantas.
- The FDA oversees drugs, vaccines, tobacco, and regulates a large part of consumer spending in the U.S.
- Makary is a British-American surgeon confirmed as FDA commissioner in March 2025.
- Makary also faced pressure from conservatives and anti-abortion groups regarding the abortion drug mifepristone.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.